Fulcrum Therapeutics (FULC) stock gains as Leerink Partners upgrades the stock, citing a favorable risk-reward setup ahead of a key trial readout. Read more here.

Rick and Morty's latest season is a dive back into familiar territory. It feels like a revered rock band at the state fair, ...

In today's fast-paced world, more and more families are looking to embrace a minimalist lifestyle, even with young children ...

Hotels are a great source of design ideas. This can work one of two ways. Some leave you feeling you could live in a place like this. Others are cautionary tales. Both are learning experiences, useful ...